We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.55%
2 Healthcare 10.82%
3 Consumer Discretionary 9.19%
4 Financials 8.34%
5 Communication Services 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZLS
4326
DELISTED
Zalatoris II Acquisition Corp Class A Ordinary Shares
ZLS
$12K ﹤0.01%
+1,261
New +$12.3K
MAQC
4327
DELISTED
Maquia Capital Acquisition Corporation Class A Common Stock
MAQC
$12K ﹤0.01%
1,205
+305
+34% +$3.1K
MRNS
4328
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$12K ﹤0.01%
2,413
-2,000
-45% -$12.2K
AFIB
4329
DELISTED
Acutus Medical Inc
AFIB
$12K ﹤0.01%
11,190
+4,007
+56% +$3.44K
VAQC
4330
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
$12K ﹤0.01%
+1,216
New +$11.9K
ARAV
4331
DELISTED
Aravive, Inc. Common Stock
ARAV
$12K ﹤0.01%
11,928
+10,662
+842% +$14.1K
HALL
4332
DELISTED
Hallmark Financial Services, Inc.
HALL
$12K ﹤0.01%
513
-865
-63% -$26.2K
MRAI
4333
DELISTED
Marpai, Inc. Class A Common Stock
MRAI
$12K ﹤0.01%
2,979
+2,916
+4,629% +$15.5K
TRKA
4334
DELISTED
Troika Media Group, Inc. Common Stock
TRKA
$12K ﹤0.01%
+644
New +$12.2K
QUMU
4335
DELISTED
Qumu Corp.
QUMU
$12K ﹤0.01%
15,193
+7,738
+104% +$9.4K
SVFA
4336
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
$12K ﹤0.01%
1,225
+828
+209% +$8.14K
OYST
4337
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$12K ﹤0.01%
2,818
+1,898
+206% +$10.8K
SCPS
4338
DELISTED
Scopus BioPharma Inc. Common Stock
SCPS
$12K ﹤0.01%
28,158
+18,971
+206% +$9.12K
KAHC
4339
DELISTED
KKR Acquisition Holdings I Corp.
KAHC
$12K ﹤0.01%
1,271
+445
+54% +$4.36K
LGV
4340
DELISTED
Longview Acquisition Corp. II
LGV
$12K ﹤0.01%
1,216
-79
-6% -$772
ZVO
4341
DELISTED
Zovio Inc. Common Stock
ZVO
$12K ﹤0.01%
12,101
+3,439
+40% +$2.81K
HAAC
4342
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
$12K ﹤0.01%
1,214
-283
-19% -$2.79K
PAQC
4343
DELISTED
Provident Acquisition Corp. Class A Ordinary Shares
PAQC
$12K ﹤0.01%
1,235
-42
-3% -$414
GBL
4344
DELISTED
GAMCO Investors, Inc.
GBL
$12K ﹤0.01%
581
-2,025
-78% -$41.8K
EMKR
4345
DELISTED
Emcore Corp
EMKR
$12K ﹤0.01%
376
-2,100
-85% -$70.7K
ABSI icon
4346
Absci
ABSI
$1.58B
$11K ﹤0.01%
3,542
-236
-6% -$1.17K
AIRT icon
4347
Air T
AIRT
$83.1M
$11K ﹤0.01%
697
-2,013
-74% -$34.8K
ALOT icon
4348
AstroNova
ALOT
$227M
$11K ﹤0.01%
950
+302
+47% +$3.9K
AMAL icon
4349
Amalgamated Financial
AMAL
$1.52B
$11K ﹤0.01%
560
+388
+226% +$7.49K
ATAI icon
4350
AtaiBeckley Inc
ATAI
$2.69B
$11K ﹤0.01%
2,968
+1,778
+149% +$7.27K

Similar funds

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.